Gynae BT_Lucknow_2018

Conclusion dose effect BT (II)

 Future Perspective EMBRACE II + clinical endpoint specific  prospective protocol: planning aims and limits for miminum prescribed dose ”soft constraints” and ”hard constraints”

taking into account multiple parameters:



Target dose CTV

(CTV

GTV

)

HR,

IR

res



Target volume CTV

(CTV

GTV

)

HR,

IR

res

 Overall treatment time <50 days

 OARs D2cm 3 and dose points (vagina, rectum)

39